Journal List > Obstet Gynecol Sci > v.61(6) > 1107507

TOOLS
Kim, Kim, Kim, Kim, Kim, Park, Park, Rhee, Lim, and Hong: Erratum: Correction of the name of society
Erratum

Obstetrics & Gynecology Science 2018; 61(6): 707.

Published online: 6 November 2018

DOI: https://doi.org/10.5468/ogs.2018.61.6.707

Erratum: Correction of the name of society

Miseon Kim, Young-Han Kim, Yong Beom Kim, Jayeon Kim, Jae-Weon Kim, Mi Hye Park, Joo Hyun Park, Jeong Ho Rhee, Myong Cheol Lim, Joon-Seok Hong

Copyright © 2018 Korean Society of Obstetrics and Gynecology

Korean Society of Obstetrics and Gynecology

(open-access):

Articles published in Obstet Gynecol Sci are open-access, distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
In the published article, “Miseon Kim, Young-Han Kim, Yong Beom Kim, Jayeon Kim, Jae-Weon Kim, Mi Hye Park, Joo Hyun Park, Jeong Ho Rhee, Myong Cheol Lim, Joon-Seok Hong. Bilateral salpingectomy to reduce the risk of ovarian/fallopian/peritoneal cancer in women at average risk: a position statement of the Korean Society of Obstetrics and Gynecology (KSOG). Obstet Gynecol Sci 2018;61(5):542-552. https://doi.org/10.5468/ogs.2018.61.5.542,” the name of society was published incorrectly. The authors apologize for any inconvenience that it may have caused.
In 2016, the Korean Society of Obstetrics and Gynecology (KSGO) recommended that women with a BRCA germline mutation should be counseled about RRSO at 35–40 years of age on an individual basis [17].
The name of society should be corrected as follows. Changes are marked by underlines:
In 2016, the Korean Society of Gynecologic Oncology (KSGO) recommended that women with a BRCA germline mutation should be counseled about RRSO at 35–40 years of age on an individual basis [17].
TOOLS
Similar articles